Skip to content

Prevalence of Port Site Hernia After Mesh Placement in Laparoscopic Cholecystectomy.

Evaluation of Port Site Hernia Prevalence After Prophylactic Mesh Placement Following Laparoscopic Cholecystectomy: Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03495557
Acronym
PSHERNIA
Enrollment
200
Registered
2018-04-12
Start date
2018-01-01
Completion date
2021-09-01
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia

Keywords

Hernia, Cholecystectomy, Mesh fixation

Brief summary

A prophylactic mesh fixation after fascial closure in umbilical trocar after cholecystectomy may prevent the trocar site hernia incidence. Especially in patients who present certain risk factors.

Detailed description

Randomized controlled trial. Patients with more than two incisional hernia risk factors (age ≥70, BMI ≥30, diabetes mellitus, fascial enlargement) who undergo elective/emergent cholecystectomy. Control arm: fascial closure with simple PDS 2/0 Stitches. Study arm: fascial closure with simple PDS 2/0 stitches and onlay polypropylene mesh placement. Main outcome umbilical trocar site hernia incidence during a 3 years follow up. Clinical and radiological assessment.

Interventions

PROCEDUREControl

Fascial closure with simple polydioxanone suture 2/0 stitches

DEVICEExperimental

Onlay polypropylene mesh placement (MN mesh)

Sponsors

Hospital de Mataró
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Control will have simple closure while experimental group will have simple closure+mesh

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Laparoscopic cholecystectomy * Emergent/elective * ≥2 risk factors: diabetes mellitus, age ≥70 years, BMI ≥30, fascial enlargement

Exclusion criteria

* Conversion to laparotomy * Emergent re intervention * Immunosuppression * Umbilical hernia

Design outcomes

Primary

MeasureTime frameDescription
Umbilical trocar site hernia incidence3 yearsUmbilical trocar site hernia incidence after 6 months and 1 year (clinical assessment) and after 3 years (radiological confirmation)

Secondary

MeasureTime frameDescription
Hematoma incidence6 monthsA localized collection of extravasated blood clotted under the tissue (clinical assessment)
Wound infection incidence6 monthsCombination of redness, swelling, warm and/or fluid drainage in the wound assessed clinically
Pain presence6 months, 1 and 3 yearsPain presence related to the umbilical wound scored from 0 (no pain) to 10 (severe pain)
Hospital discharge48 hoursWhen patients leave the hospital after the intervention, measured by hours
Seroma incidence6 monthsA mass or tumefaction caused by the localized accumulation of serum within the tissue (clinical assessment)
Return to regular activity6 monthsWhen patient return to job or regular activities after surgery, measured by days
Patient satisfaction3 yearsHow satisfied/unsatisfied is the patient with the whole process measured by a survey form which classify it in a range from 0 (very unsatisfied) to 5 (very satisfied)
Surgeon satisfaction3 yearsHow satisfied/unsatisfied is the surgeon with the whole process measured by a survey form which classify it in a range from 0 (very unsatisfied) to 5 (very satisfied)
Operative time2 hoursIntervention duration, measured by minutes

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026